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Abstract
 
Toll-like receptor (TLR) signaling and phagocytosis are hallmarks of macrophage-mediated
innate immune responses to bacterial infection. However, the relationship between these two
processes is not well established. Our data indicate that TLR ligands specifically promote bacterial
phagocytosis, in both murine and human cells, through induction of a phagocytic gene program.
Importantly, TLR-induced phagocytosis of bacteria was found to be reliant on myeloid differ-
entiation factor 88–dependent signaling through interleukin-1 receptor–associated kinase-4
and p38 leading to the up-regulation of scavenger receptors. Interestingly, individual TLRs
promote phagocytosis to varying degrees with TLR9 being the strongest and TLR3 being the
weakest inducer of this process. We also demonstrate that TLR ligands not only amplify the
percentage of phagocytes uptaking
 
 Escherichia coli
 
, but also increase the number of bacteria
phagocytosed by individual macrophages. Taken together, our data describe an evolutionarily
conserved mechanism by which TLRs can specifically promote phagocytic clearance of bacteria
during infection.
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Introduction
 
Bacterial infection is a major cause of illness and morbidity
in multicellular organisms. In the innate immune system,
macrophages play a key role in combating infection. Macro-
phages rely heavily on phagocytosis and subsequent degra-
dation of microbes in order to help clear the body of invading
pathogens (1). Pathogens are detected by macrophages
through a variety of pattern recognition receptors (PRRs;
reference 2). This, in turn, leads to receptor-mediated endocy-
tosis, digestion of the pathogen, and presentation of antigens
in the context of MHC.
In addition to direct pathogen uptake, other classes of
PRRs, such and toll-like receptors (TLRs), play essential
roles in activating signal transduction pathways leading to
the killing and clearance of pathogens. TLRs recognize
highly conserved, pathogen-coded molecular structures
termed pathogen-associated molecular patterns (PAMPs;
reference 3). A great deal has been learned in the past 10
years regarding specific recognition of microbial PAMPs by
individual TLRs (4). For example, TLR4 recognizes LPS
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-diamidino-2-phenylindole; ERK 1/2, extracellular signal–related
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from gram-negative bacteria whereas TLR9 recognizes
bacterial hypomethylated CpG DNA motifs. After ligand
binding, all TLRs sequentially recruit the adaptor mole-
cules myeloid differentiation factor 88 (MyD88), IL-1 re-
ceptor–associated kinase (IRAK), and tumor necrosis factor
receptor–associated factor 6 (TRAF6). These adaptors in
turn mediate the activation of the jun NH
 
2
 
-terminal kinase
(JNK), nuclear factor (NF)-
 
 
 
B, p38, extracellular signal–
related kinase 1/2 (ERK 1/2), and phosphoinositide
3–kinase signaling pathways leading to activation of in-
flammatory target genes (5).
Significant progress has been also made in describing the
inflammatory and antimicrobial responses induced by indi-
vidual TLRs (6–8). Inflammation is promoted by TLRs
through the production of cytokines such as TNF-
 
 
 
 and
IL-I
 
 
 
 (9). TLR activation also promotes recruitment of in-
flammatory cells (10), and has been shown to mediate di-
rect antimicrobial activity against intracellular bacteria (11).
Moreover, a few studies have suggested that certain TLR
ligands may play a role in modulating the ability of macro-
phages to bind extracellular bacteria (12–14). However, the
ability of various TLRs to directly modulate macrophage
phagocytosis remains unclear, and no molecular mecha-
nism for such a process has been described.
In our current study, we demonstrate that numerous TLR
ligands specifically enhance phagocytosis of bacteria such as
 
Escherichia coli
 
 and 
 
Staphylococcus aureus
 
, while exhibiting min-
imal effects on nonbacterial targets such as latex beads. Vari-
ous TLRs differentially promote phagocytosis through in-
duction of a phagocytic gene program, with TLR9 being the
strongest mediator of this process and TLR3 being the
weakest. In addition, we show that TLR-mediated induc-
tion of scavenger receptors (SRs) occurs through MyD88,
IRAK4, and p38, and that activation of this pathway is es-
sential for TLR promotion of phagocytosis. This mechanism
appears to be evolutionarily conserved between mice and
humans, suggesting that this pathway is a critical mediator of
bacterial clearance by mammals after infection.
 
Materials and Methods
 
Cell Culture and Reagents.
 
Murine bone marrow–derived
macrophages (BMMs) were differentiated from marrow as de-
scribed previously (6). A129 (IFNAR-1
 
 
 
/
 
 
 
; reference 15) and
B6129SF2/J wild-type control mice were obtained from B&K
Universal Ltd. and Jackson ImmunoReasearch Laboratories, re-
spectively. Mice deficient in MyD88 and littermate controls were
obtained from Shizuo Akira (University of Osaka, Osaka, Japan).
C57/B6 mice were used for all experiments not involving the
A129 or MyD88-deficient mice (Jackson ImmunoReasearch
Laboratories). RAW 264.7 murine macrophage cells were cul-
tured in DMEM media supplemented with 10% fetal bovine se-
rum and 100 U/ml penicillin and 100 
 
 
 
g/ml streptomycin.
THP-1 human monocytes were cultured in RPMI media supple-
mented with 10% fetal bovine serum, 100 U/ml penicillin, and
100 
 
 
 
g/ml streptomycin. Peripheral blood mononuclear cells
were isolated from human whole blood using Ficoll-Paque (Am-
ersham Biosciences) density gradient centrifugation following the
manufacturer’s recommended protocol. Monocytes were en-
 
riched using Percoll (Amersham Biosciences) density gradient
centrifugation and then adhered onto plastic plates for 2 h in
RPMI containing 1% fetal bovine serum (Hyclone). The nonad-
herent cells are washed off with PBS and the adherent cells are
cultured in complete RPMI supplemented with 10% fetal bovine
serum, 100 U/ml penicillin, and 100 
 
 
 
g/ml streptomycin, and
treated with stimuli. Specific TLR activation was achieved using
F-583 (Rd mutant) 
 
E. coli
 
 lipid A for TLR4 (Sigma-Aldrich),
CpG oligonucleotides for TLR9 (Invitrogen), purified pepti-
doglycan (PGN) from 
 
Staphylococcus aureus
 
 (Sigma-Aldrich) for
TLR2, polyinosinic acid (poly I):C for TLR3 (Amersham Bio-
sciences), and imiquimod for TLR7 (Sequoia Research). ERK 1/2
and p38 were both inhibited using 10 
 
 
 
M uo126 or sb202190,
respectively (Calbiochem). Poly I was obtained from Sigma-
Aldrich and added to cells 1 h before bacterial challenge. Macro-
phage colony-stimulating factor (M-CSF)–containing media was
obtained by growing L929 cells 4 d past confluency and then har-
vesting the conditioned media.
 
RNA Quantitation.
 
For microarray studies, BMMs were treated
with media or 1 ng/ml lipid A for 4 h or 1 
 
 
 
g/ml poly I:C or 100
nM CpG for 4 or 12 h. After stimulation, total RNA was extracted
and labeled cRNA synthesized as described previously (6). The la-
beled cRNA was used to hybridize to Affymetrix Mu11K chip sets
and data analyzed using Affymetrix Microarray Suite 4.0 data mining
software. To identify PAMP-induced genes, comparisons were per-
formed using the media-only–treated sample as a baseline. Genes
were considered induced if they displayed (a) a threefold change rel-
ative to baseline, (b) they had a poststimulation average difference (a
value representing absolute expression level) of at least 500, and (c)
they had an average difference change relative to baseline of at least
600 (roughly twice chip background). Average difference change
values for genes involved in phagocytosis were processed using Clus-
ter and data presented as a dendrogram using the Treeview program
(www.rana.lbl.gov/EisenSoftware.htm). For quantitative realtime
PCR 
 
(
 
Q-PCR), total RNA was isolated and cDNA synthesized as
described previously (6). PCR was then performed using the iCycler
thermocycler (Bio-Rad). 
 
I
 
 
 
B
 
 
 
, 
 
L32
 
, and intercellular adhesion mol-
ecule-1(
 
ICAM-1
 
) primers were the same as those described previ-
ously (6, 16). The following primers were synthesized by Invitrogen:
macrophage SR with collagenous structure (
 
MARCO
 
) forward
ATCCTGCTCACGGCAGGTACT, and reverse GCACATC-
TCTAGCATCTGGAGCT, scavenger receptor-A (
 
SR-A1
 
) for-
ward TCCTTGCAGAGTCTGAATATGACACT, and reverse
CCTCCTGTTGCTTTGCTGTAGATT, lectin-like oxidized LDL
receptor (
 
LOX-1
 
) forward GTGGACACAATTACGCCAGGTA,
and reverse GCCCTTCCAGGATACGATCC, and 
 
IL-1
 
 
 
 forward
GAGCTGAAAGCTCTCCACCTCA, and reverse TCGTTGCT-
TGGCTCCTTGTAC. It is of note that we refer to SR-A1 mRNA
as SR-A throughout this manuscript.
 
EMSA, Western Blotting, and GST Pulldown Assays.
 
For
EMSA, BMMs were stimulated with TLR ligands and nuclear
extracts were prepared as described previously (17). For p38 and
phosphorylated p38 immunoblotting, cells were lysed in modified
RIPA buffer (50 mM Tris-Cl, pH 8.0, 150 mM NaCl, 5 mM
EDTA, 1% Triton X-100, 0.1% SDS, 1% sodium deoxycholate
containing 2 
 
 
 
g/ml aprotinin, 1 
 
 
 
g/ml leupeptin, 1 
 
 
 
g/ml pep-
statin, and 100 
 
 
 
g/ml PMSF) containing protease and phos-
phatase inhibitors and 40 
 
 
 
g of protein was loaded per lane and
separated by SDS-PAGE on 10% gels. After transfer, nitrocellu-
lose filters were immunoblotted using anti-p38 and antiactivated
p38 antibodies from Cell Signaling Technologies as per manufac-
turer’s recommendations. A human pEFBOS.TLR9 construct
was provided by Shizuo Akira. ESTs containing the intracellular 
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domain of hTLR3 and full-length hMyD88 were obtained from
Research Genetics. The cloning of the intracellular domains of
TLR3 and TLR9 into expression vectors and binding assays were
performed as described previously (16).
 
Phagocytosis Assays. 
 
For each experiment, the green fluores-
cence protein (GFP)–expressing 
 
E. coli
 
 (a gift from Dr. Jeff F.
Miller, UCLA, Los Angeles, CA) were grown up from a single
colony in Luria-Bertani broth containing 100 
 
 
 
g/ml ampicillin.
The culture was then subcultured and grown until log phase
growth was obtained. Bacteria were then washed in PBS two
times and then resuspended at the appropriate concentration in
either DMEM or RPMI media without serum or antibiotics.
Before infection, macrophages were washed two times in media
without serum or antibiotics before bacterial challenge. BMMs
and RAW264.7 cells were infected with GFP–
 
E. coli
 
 at an mul-
tiplicity of infection (MOI) of 5 or 25, respectively. The optimal
time point for measurement of phagocytosis was determined to
be at 45 min after infection. Macrophage cells were then washed
with cold PBS in order to stop additional bacterial uptake or de-
struction of bacteria in the phagolysosome. Cells were washed a
total of three times in cold PBS before harvesting in cold PBS
containing 5 mM EDTA. Cells were then fixed using parafor-
maldehyde (1% final concentration) and then subjected to
FACS
 
®
 
 analysis. Experiments using acetylated low-density lipo-
proteins (Molecular Probes), fluorescently labeled latex beads
(Sigma-Aldrich), or BODIPY
 
®
 
–conjugated 
 
S. aureus
 
 (Wood
strain without protein A) BioParticles
 
®
 
 (Molecular Probes) were
performed in a similar fashion at 5 
 
 
 
g/ml, at an MOI of 1 or 10,
respectively.
 
Flow Cytometry, Laser Scanning Cytometry, and Fluorescence Mi-
croscopy.
 
 MARCO and SR-A protein expression on the mac-
rophage cell surface was detected by using an anti-MARCO–
FITC antibody (clone ED31; 1 
 
 
 
g/ml, along with IgG1 isotype
control), or anti–SR-A–FITC antibody (clone 2F8, which recog-
nizes both SR-AI and SR-AII isoforms; 1 
 
 
 
g/ml, along with
IgG2b isotype control), respectively. These antibodies, along
with unconjugated anti–SR-A–blocking antibody (clone 2F8),
were obtained from Serotec, Inc. An anti-CD11c antibody con-
jugated to PE was obtained from Becton Dickinson. All staining
antibodies were diluted in FACS
 
®
 
 buffer (phosphate-buffered sa-
line, 1% bovine serum albumin, 1% fetal calf serum, 0.1% sodium
azide) containing 1% normal mouse serum. FACS
 
®
 
 analysis was
conducted using a FACSCaliber
 
®
 
 (Becton Dickinson) machine
and CellQuest software (Becton Dickinson). To assess changes in
phagocytic efficiency, RAW 264.7 cells were plated in eight-well
chamber slides (Nalge NUNC) and treated as indicated. Cells
were fixed with 4% paraformaldehyde for 30 min and analyzed
with a laser scanning cytometer (CompuCyte). Cells were coun-
terstained with 6
 
 
 
-diamidino-2-phenylindole (DAPI; Molecular
Probes) at a concentration of 10 
 
 
 
g/ml to identify DNA and to
distinguish cell cycle stage. The UV laser was used to contour on
DAPI using a minimum cell area of 20 
 
 
 
m. The argon laser was
used to measure fluorescence of GFP–
 
E. coli
 
 shown as percent of
cells that have been phagocytosed by macrophages. The number
of GFP–
 
E. coli
 
 per cell was measured by 
 
laser scanning micros-
copy 
 
using ultraviolet light to excite DAPI and the argon laser
was used to measure GFP fluorescence within a minimum of 2
pixels in area. LSC-based fluorescence in situ hybridization
(FISH) analysis software was used to show the total number of
GFP–
 
E. coli
 
 per macrophage. The LSC was used to photograph
the GFP–
 
E. coli
 
 with a CCD camera and colored with Com-
puCyte color software (Laser Scanning Cytometry). For fluores-
cence microscopy a Leica DM IRBE fluorescent microscope us-
ing 10
 
 
 
 and 63
 
 
 
 objectives (Leica Microsystems) and Openlab
software (Improvision) was used for image acquisition. Cells were
counter stained with DAPI and then stained with rhodamine–
phalloidin (Molecular Probes) as per the manufacturer’s protocol
to label cytoskeletal F-actin.
Figure 1. TLR ligands spe-
cifically increase macrophage
phagocytosis of bacteria. (A)
RAW 264.7 macrophage cells
were pretreated with media,
CpG (100 nM), PGN (20  g/ml),
lipid A (50 ng/ml), or poly I:C
(10  g/ml) for 24 h and then
challenged with GFP–E. coli at
an MOI of 25. (B) RAW 264.7
cells pretreated with 100 nM
CpG or media alone were
treated with fluorescently labeled
latex beads at an MOI of 1. (C)
BODIPY®-conjugated  S. aureus
BioParticles® at an MOI of 10.
(D) THP-1 monocytes were
treated with media or PGN (20
 g/ml) for 36 h. Cells were
then challenged with GFP–E.
coli at an MOI of 5, and analyzed
for the presence of phagocy-
tosed bacteria. (E) Primary human
monocytes were collected from
four independent human donors
(donor 1, square; donor 2, circle;
donor 3, diamond; donor 4, tri-
angle; mean, line) and subjected
to the same phagocytosis experiments as in D. After microbial or particle challenge, cells were washed and subjected to FACS® analysis. All
FACS® data are represented as percent positive cells. Data are representative of at least two independent experiments. 
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Results
 
TLR Ligands Specifically Enhance Phagocytosis of Bacteria.
 
To determine the role of TLRs in promoting phagocytosis,
we pretreated RAW 264.7 murine macrophage cells with
TLR ligands and measured the uptake of the GFP-labeled
Topp10 strain of 
 
E. coli
 
. We chose to perform these exper-
iments using the RAW264.7 cell line because we found
that these cells have a low basal level of phagocytosis as de-
termined by FACS
 
®
 
 (Fig. 1 A). As shown in Fig. 1 A, pre-
treatment of these cells with various TLR ligands markedly
enhanced the level of phagocytosis of the gram-negative
bacterium 
 
E. coli
 
. We also found that TLR activation leads
to increased uptake of BioParticles
 
®
 
 derived from the
gram-positive bacterium 
 
S. aureus
 
 (Fig. 1 C). Different
TLRs promoted phagocytosis to different extents, with
TLR9 being the strongest, followed by TLR2 and TLR7
(data not shown) and TLR4 and TLR3 being the weakest
inducers of this process.
To determine if TLR-induced phagocytosis is specific
for bacteria, or whether it represents an uptake pathway
that can target various products, we performed phagocyto-
sis experiments using fluorescently labeled latex beads or
acetylated low-density lipoproteins. Fig. 1 B shows that
CpG pretreatment results in only a mild increase in the
phagocytosis of latex beads by macrophage cells as com-
pared with media-pretreated samples. Uptake of acetylated
 
low-density lipoproteins was also only minimally increased
after TLR activation (data not shown). These findings sug-
gest that TLR ligands induce a phagocytic phenotype that
can specifically target both gram-negative and -positive
bacteria. Moreover, TLRs seem to have diverged function-
ally with individual TLRs being able to promote phagocy-
tosis to varying degrees.
To determine if TLR-induced phagocytosis is an evolu-
tionarily conserved process, we first tested the human
monocyte cell line THP-1. Because human monocytes are
unresponsive to CpG, we used the TLR2 ligand PGN as it
was also a relatively strong inducer of phagocytosis in our
murine studies and was also able to induce IL-12 p40 pro-
duction (data not shown). Fig. 1 D demonstrates that PGN
pretreatment significantly increased the ability of THP-1
cells to ingest 
 
E. coli
 
. We next wanted to test if primary hu-
man monocytes also have increased phagocytic capabilities
after TLR activation. PGN treatment was also able to signif-
icantly up-regulate phagocytosis in primary human mono-
cytes, causing a roughly twofold increase in the percent of
cells containing bacteria (Fig. 1 E). In addition, we noticed a
correlation between the degree of IL-12 p40 induction (a
control for efficient TLR2 stimulation and basal activation
state of the monocytes used) and the level of increase in
phagocytosis after PGN treatment (data not shown).
Figure 2. TLR ligands induce expression
of genes involved in phagocytosis. Murine
bone marrow–derived macrophage cells
were stimulated with media (m), CpG (100
nM), lipid A (1 ng/ml), or poly I:C (1  g/
ml) for the indicated times. (A) Total RNA
was collected after 4 or 12 h of TLR ligand
stimulation and subjected to a microarray
analysis as described in Materials and Methods.
A subset of genes involved in phagocytosis is
depicted as a dendrogram. Red represents
up-regulation of the gene, black represents
no change in expression, and green repre-
sents down-regulation of the gene. (B) Nu-
clear extract from each sample (2  g) was used
to assay inducible DNA binding of NF- B
by EMSA (top), or RNA was collected, con-
verted to cDNA, and subjected to Q-PCR
analysis to assay I B  gene induction by 1 h
(bottom). (C) Total RNA was collected
from BMMs treated with indicated PAMPs,
converted to cDNA, and Q-PCR was used
to verify expression of MARCO, SR-A, and
LOX-1 using sequence specific primers. (D)
BMMs were stimulated with TLR ligands
for 24 h and cells were stained with
anti-MARCO–FITC antibody to detect
MARCO via FACS®. The data are repre-
sented as percent-positive cells. Q-PCR
data are represented in relative expression
units and all values have been normalized to
L32. All data, except the microarray, are
representative of at least three independent
experiments. 
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TLRs Induce Genes Involved in Phagocytosis.
 
To define
the molecular mechanisms underlying the TLR-induced
phagocytic phenotype observed in Fig. 1, we analyzed
TLR-regulated target genes on a global basis. Murine
bone marrow–derived macrophage cells (BMMs) were
treated with CpG, lipid A, and poly I:C for 4 and 12 h,
and then subjected to a microarray analysis to assess target
gene expression changes (Fig. 2 A). We selected the con-
centrations of TLR ligands used as they gave relatively
equal activation of NF-
 
 
 
B by electrophoretic mobility
shift assay (EMSA; Fig. 2 B, top), as well as equal up-regu-
lation of 
 
I B  mRNA, suggesting a similar strength of sig-
nal (Fig. 1 B, top). Upon analyzing the microarray results,
we identified a number of genes that were up-regulated by
TLR9, TLR4, and TLR3 that are involved in phagocyto-
sis (Fig. 2 A). Genes such as CD36, thrombospondin, and
the apoptotic cell clearance receptor are known to be involved
in the clearance of apoptotic cells (18–20). In addition,
genes involved in opsonin-dependent phagocytosis (Fc and
complement receptor genes as well as Lyn and Syk) were
found to be up-regulated by TLRs (21, 22). We also no-
ticed a number of genes involved in opsonin-independent
phagocytosis of bacteria. Among these genes were a subset
of SRs, including MARCO and SR-A (23). Genes coding
for certain signaling molecules (Protein Kinase C   and Lyn)
that are thought to act downstream of SRs were also up-
regulated (24).
Although TLR3, TLR4, and TLR9 all induced comple-
ment, Fc, and SRs, we chose to focus on SRs due to their
ability to directly interact with microbes under nonopsonized
conditions (same conditions used in Fig. 1). Using Q-PCR
analysis, we confirmed the inducible expression of SR-A and
MARCO by the different TLR ligands (Fig. 2 C). We also
tested the expression of other SRs and found that LOX-1 was
also induced by TLR ligands at early time points (Fig. 2 C).
Similar to the pattern of induction obtained in our phagocy-
tosis assays, we found that TLR9 induced the expression of
these genes to the highest degree, whereas TLR4-mediated
induction was more intermediate and TLR3 was the weakest
inducer of the SRs tested. In addition, whereas both TLR9
and TLR4 were able to up-regulate all three of these genes,
TLR3 was only able to induce LOX-1 and SR-A, but not
MARCO. To determine if induction of SR transcript corre-
lated with increased levels of protein we performed flow cy-
Figure 3. TLRs use a MyD88–IRAK4–p38 signaling
pathway in order to induce expression of the SRs
MARCO,  LOX-1, and SR-A. (A) BMMs from
MyD88 / , IRAK4 /  mice, or wild-type BMMs
pretreated with either sb202190 (sb, 10  M) or uo126
(10  M) were stimulated with media (m) or CpG (100
nM) for 4 or 12 h. Total RNA was collected, con-
verted to cDNA, and then Q-PCR was used to assay
the inducible expression of SR-A, LOX-1, and
MARCO under the different conditions. To control
for specificity of p38 and ERK 1/2 inhibition, induction
of ICAM-1 and IL-1  were also measured. Q-PCR
data are represented in relative expression units and
normalized to L32. (B) Wild-type, MyD88 / ,
IRAK4 / , and sb202190 (10  M) pretreated wild-
type BMMs were stained for MARCO surface expression
after 24 h of media, CpG (100 nM), lipid A (1 ng/ml),
or poly I:C (1  g/ml) treatment and FACS® data are
represented as the mean fluorescent intensity (MFI) of
each cell population. (C) RAW 264.7 cells were stim-
ulated with CpG (100 nM) or PGN (20  g/ml) for
24 h, either in the presence of absence or 10  M
sb202190, stained with a FITC-labeled  SR-A anti-
body, and then analyzed by FACS®. (D) BMMs from
wild-type and IRAK4 /  mice were stimulated with
media or CpG (100 nM) for the indicated times.
Whole cell extract was then subjected to immunoblotting
to detect phosphorylated (activated) p38 or total p38.
(E) 293T cells were transfected with a MyD88 expression
vector. Extract was collected and incubated with glu-
tathione beads containing either TLR9 (intracellular
domain)–GST, TLR3 (intracellular domain)–GST, or
GST alone. Bound MyD88 was eluted by boiling and
visualized by immunoblotting using an anti-MyD88
polyclonal antibody. The dashed line represents a
cropping border where irrelevant lanes have been
removed. Data are representative of at least two inde-
pendent experiments.A Mechanism of TLR-mediated Phagocytosis 86
tometry using antibodies specific to SR-A and MARCO and
found that TLRs can induce expression of these proteins
(Fig. 2 D and Fig. 3, B and C). These data suggest that TLRs
promote phagocytosis though the up-regulation of a phago-
cytosis gene program that includes SRs.
TLRs Use MyD88, IRAK4, and p38 to Induce SRs.
The signal transduction pathways activated by different
TLRs are known to differ. Some TLRs preferentially acti-
vate the MyD88-dependent pathway whereas others also ac-
tivate the MyD88-independent pathway (25, 26). Due to
this fact, we wanted to clarify which TLR signaling arm was
responsible for the inducible expression of these SRs. Using
mice deficient in MyD88, we show in Fig. 3 A that MyD88
is required for the inducible expression of MARCO, LOX-1,
and SR-A at the mRNA level in response to TLR9 stim-
ulation with CpG. This dependency was also verified for
MARCO at the protein level (Fig. 3 B). In addition, we
found that autocrine/paracrine induction of type 1 inter-
feron does not contribute to TLR9- or TLR4-induced
LOX-1 or MARCO expression, indicating that the MyD88-
independent pathway does not play a role in the up-regula-
tion of the SRs tested (data not shown; reference 6).
Recently, the serine–threonine kinase IRAK4 has been
shown to be an important component of the MyD88-depen-
dent pathway (27). To determine if the TLR–MyD88 sig-
nal that is responsible for SR up-regulation is mediated
through IRAK4, we stimulated BMMs deficient in IRAK4
with CpG and assessed the up-regulation of MARCO and
LOX-1. Identical to MyD88 knockout BMMs, the IRAK4
deficiency ablated up-regulation of these TLR target genes
(Fig. 3 A). This IRAK4 requirement was also verified at
the protein level for MARCO (Fig. 3 B).
In an effort to determine which signaling pathway
downstream from IRAK4 is required for SR gene expres-
sion, we used different pharmacological inhibitors to block
known TLR signaling pathways including p38 (sb202190)
and ERK 1/2 (uo126). We used a concentration of 10  M
for each of these inhibitors because we found that this con-
centration led only to inhibition of the intended pathway
and did not nonspecifically affect other signaling pathways
(unpublished results). Supporting this claim, ICAM-1 in-
duction (whose transcription is NF- B dependent) is not
effected by treatment with sb202190 (Fig. 3 A). However,
inhibition of p38 activity, but not ERK 1/2 activity,
blocked TLR-induced expression of SR transcripts in re-
sponse to CpG (Fig. 3 A). FACS® analysis shows that TLRs
also potently up-regulate MARCO and SR-A at the pro-
tein level and that inhibition of p38 activity completely
blocks this induction (Fig. 3, B and C). The effectiveness of
uo126 is exemplified by the fact that TLR-induced IL-1 
transcription is greatly reduced after blockade of ERK 1/2
with this compound (Fig. 3 A).
In IRAK4-deficient mice, p38 activation is completely
abolished after IL-1  treatment (27). Additionally, it has
been shown that CpG-mediated p38 activation is com-
pletely abolished in the absence of MyD88 (28). To deter-
mine if IRAK4 is also required for p38 activation down-
stream from TLR9, we treated IRAK4 /  BMMs with
CpG and assessed p38 activation by conducting Western
blotting using an antibody that specifically recognizes phos-
phorylated p38. We found that in the absence of IRAK4,
p38 was no longer activated by TLR9 signaling (Fig. 3 D).
As previously mentioned, we had noticed that TLR9 was
overall the strongest inducer of SR expression, whereas
TLR3 was the weakest (Fig. 2, A and C). Because the signal-
ing events leading to SR expression appear to be dependent
on MyD88, we tested the relative affinities of the cytoplasmic
domains of TLR3 and TLR9 for MyD88. We show in Fig.
3 E that the GST–TLR9 intracellular domain has a higher af-
finity for MyD88 than does GST–TLR3 intracellular do-
Figure 4. TLR-induced phagocytosis of bacteria is
MyD88, p38, and SR dependent. (A) BMMs derived
from either wild-type or MyD88-deficient mice were
stimulated with media or 100 nM CpG for 24 h fol-
lowed by infection with GFP-expressing E. coli at an
MOI of 10 for 45 min. Cells were washed twice with
cold PBS and subjected to FACS® analysis. (B) RAW
264.7 macrophage cells were stimulated with media,
CpG (100 nM), or PGN (20  g/ml) for 24 h. Cells
were cotreated with 10  M sb202190 for the entire
duration of the media, CpG or PGN pretreatment, or
just for the final 1 h. Cells were then challenged with
GFP–E. coli for 45 min at an MOI of 25, washed, and
subjected to FACS® analysis. (C) RAW 264.7 cells
were pretreated with either media, CpG (100 nM), or
PGN (20  g/ml) for 24 h. For the final 1 h, the cells
were treated with poly I (100  g/ml), anti–SR-A (3  g/
ml), or IgG2b isotype control (3  g/ml) and phagocy-
tosis assays were performed. (D) THP-1 monocytes
were treated with media or PGN (20  g/ml) for 36 h.
The same conditions were also used along with
sb202190 (10  M) for 36 h or poly I (100  g/ml) for
the final 1 h of TLR ligand pretreatment. Cells were
then challenged with GFP–E. coli at an MOI of 5,
washed, and subjected to FACS® analysis. Data represent
at least two independent experiments.Doyle et al. 87
main using pulldown assays with overexpressed MyD88.
Collectively, these data suggest that TLRs differentially up-
regulate a subset of bacterial binding SRs via a MyD88–
IRAK4–p38-dependent pathway. In addition, the strength
of signaling activated by various TLRs may be determined by
the relative affinity of these different TLRs for MyD88.
TLR-induced Bacterial Phagocytosis Is MyD88, p38, and SR
Dependent. To determine if TLR-induced phagocytosis
of bacteria is dependent on MyD88–IRAK4–p38-medi-
ated SR up-regulation, we first compared TLR-induced
phagocytosis of bacteria by BMMs derived from wild-type
and MyD88 knockout mice (Fig. 4 A). Although BMMs
have a high basal level of phagocytosis relative to RAW
264.7 cells, which is likely due to up-regulation of SR-A
by M-CSF in the culture media (data not shown; and refer-
ences 29 and 30), CpG pretreatment still significantly in-
creases bacterial uptake by BMMs in a MyD88-dependent
manner. Interestingly, the basal level of BMM phagocytosis
was significantly decreased in MyD88 /  macrophage cells
compared with wild-type controls.
We next tested whether or not inhibiting the p38 signal-
ing pathway could prevent TLR-induced phagocytosis. In
agreement with our data showing that p38 is required for
the TLR-mediated up-regulation of SRs such as MARCO
and SR-A (Fig. 3, A–C), the TLR-dependent increase in
phagocytosis of E. coli was completely blocked by the p38
inhibitor (Fig. 4 B). However, if the RAW 264.7 macro-
phage cells were pretreated with TLR ligands and given
the p38 inhibitor for only 1 h before bacterial challenge,
TLR-induced phagocytosis was relatively unaffected (Fig.
4 B). These data suggest that TLR-induced augmentation
of phagocytosis requires p38 for the up-regulation of
phagocytic mediators such as SRs, but is p38 independent
once these proteins are in place on the cell surface.
SR-A has been shown to play an important role in bacte-
rial phagocytosis (29, 31). Furthermore, mice with a tar-
geted disruption of the SR-A gene have defects in bacterial
clearance (31). Thus, we sought to determine if TLR-
inducible phagocytosis specifically involved SR-A. Fig. 4 C
reveals that a blocking antibody against SR-A, but not the
antibody isotype control, significantly reduced TLR-induced
phagocytosis. Because the block was not complete, it
implied that other SRs may be involved in the uptake of
bacteria. To test if this is the case, we performed phagocyto-
Figure 5. TLR activation results in an
increase in the number of bacteria per indi-
vidual macrophage. (A) RAW 264.7 cells
were pretreated with media or CpG (100
nM) for 24 h, phagocytosis assays were per-
formed using GFP–E. coli (green), and cells
were fixed, stained with DAPI (blue) to
stain chromosomal DNA and rhodamine-
phalloidin (red) to stain cytoplasmic F-actin,
and subjected to fluorescence microscopy at
both 10  and 63  resolution. (B) The
same cells as seen in A were subjected to
LSC-based FISH analysis using the LSC to
determine the number of GFP signals on a
per cell basis. Data are represented as the
number of macrophage cells (out of 5,000
scanned) that had either 1, 2, 3, 4, 5, or  6
GFP signals per cell. Pictures along the x
axis are representative of macrophage cells
in each grouping that were counted by the
LSC. Data represent at least two indepen-
dent experiments.A Mechanism of TLR-mediated Phagocytosis 88
sis assays in the presence of the SR inhibitor, poly I. These
experiments showed that TLR-inducible phagocytosis was
almost completely inhibited by poly I and indicated that
multiple SRs are, in fact, involved in the TLR-mediated
potentiation of bacterial phagocytosis (Fig. 4 C). The in-
volvement of multiple SRs in TLR9- and TLR2-induced
bacterial phagocytosis correlates with a p38-dependent in-
crease in expression of not only SR-A but also MARCO
and LOX-1 after CpG treatment (Fig. 3, A–C). These data
imply that TLR-inducible macrophage phagocytosis of bac-
teria is through a MyD88–IRAK4–p38-dependent up-reg-
ulation of multiple SRs that, together, contribute to an
overall increase in bacterial binding and phagocytosis.
TLR Activation Causes an Increase in Phagocytic Efficiency.
The broad shift in mean fluorescence intensity present in
the FACS® data (Fig. 1 A) from our phagocytosis assays
suggested that TLR ligand treatment may not only cause an
increased number of macrophages able to participate in
bacterial phagocytosis, but they also promote an increase in
the amount of bacteria uptake by individual macrophage
cells. Fluorescence microscopy confirmed this, showing
that TLR ligand treatment of RAW 264.7 cells not only
causes an increase in the number of cells engaged in phago-
cytosis, but also an enhancement in the number of E. coli
taken up per individual macrophage cell (Fig. 5 A). We
used LSC to quantitate the observed increase in the num-
ber of bacteria localized within individual macrophages
(32). We found LSC to be comparable to FACS® in deter-
mining the percentage of TLR-induced phagocytic cells
(data not shown). We performed an LSC-based FISH anal-
ysis, which enabled us to determine the topographic distri-
bution of E. coli, and therefore allowed us to measure the
number of bacteria bound or phagocytosed by each macro-
phage cell. These experiments showed quantitatively that
CpG pretreatment of macrophages causes a great increase
in the number of E. coli phagocytosed per individual mac-
rophage, as compared with the media control (Fig. 5 B). In
addition, treatment with sb202190 (sb) showed that this in-
crease in phagocytic efficiency was found to be dependent
on p38. Similar results were also obtained for cells pre-
treated with PGN. LSC-based FISH analysis revealed that
human monocytes also take up a larger number of bacteria
after TLR2 activation (data not shown). Our data suggest
that all TLR ligands tested can induce macrophage phago-
cytosis of E. coli to varying degrees. Interestingly, TLR2
and TLR9 caused the greatest increase in bacterial uptake,
with TLR9 being the strongest potentiator out of all of the
TLRs tested. Furthermore, we found that TLR-induced
nonopsonized phagocytosis can increase both the number
of phagocytic cells in the population as well as the number
of E. coli taken up on a per cell basis.
Discussion
Phagocytosis, a hallmark function of macrophage cells in
innate immune responses, involves a series of coordinated
events including recognition of pathogens by cell surface
receptors, receptor-mediated endocytosis, fusion of the
phagosome with the endosome, digestion of pathogens, as
well as presentation of antigens through MHC. The regu-
lation of these individual events during host infection by
pathogen, however, is complex and not well understood.
TLR family members represent a major class of innate im-
mune receptors abundant on the surface of macrophage
cells. A great deal has been learned in the past 10 years re-
garding the recognition of microbial PAMPs by individual
TLRs, and the inflammatory response genes induced by
these TLRs. Whereas certain TLRs such as TLR3 and
TLR4 have been shown to have antiviral activity through
the production of IFN  (6), relatively less is known about
the role of TLRs in mediating direct antibacterial re-
sponses. Our current study characterizes a molecular mech-
anism that clearly links TLRs to macrophage-mediated
phagocytosis of bacteria.
We have identified a TLR-inducible gene subset that is
indicative of enhanced macrophage bacterial binding and
uptake. Among this subset of genes are SRs including SR-A,
LOX-1, and MARCO. The role of SR-A in TLR-induced
phagocytosis was demonstrated by using a blocking anti-
body specific for SR-A. Indeed, mice with targeted disrup-
tion of the SR-A gene have defects in bacterial clearance
(31). The fact that the general SR inhibitor poly I can fur-
ther inhibit TLR-induced phagocytosis in both human and
mouse cells suggests that other SRs must assist SR-A in
binding and phagocytosing of bacteria. In addition to SRs,
TLRs mediate the induction of other genes involved in the
recognition of pathogens and apoptotic cells including the
mannose-6-phosphate receptor, ABC1, complement receptors (33–
38). The microarray results also demonstrate that each
TLR tested can induce both common and specific genes
involved in phagocytosis, which suggests that different
TLRs can induce unique combinations of phagocytic me-
diators that may differentially target pathogens.
Our data support a model whereby TLRs transduce sig-
nals through MyD88, IRAK4, and p38 resulting in the up-
regulation of SRs, leading to a significant increase in mac-
rophage/monocyte phagocytosis of gram-negative and
-positive bacteria. The TLR-mediated increase in phago-
cytosis appears to be specific for bacteria since only a slight
increase in uptake of either latex beads or acetylated low-
density lipoproteins was observed. These data are especially
interesting since uptake of acetylated low-density lipopro-
teins is also mediated by SRs and suggest that TLRs may be
able to differentially regulate the ability of SRs to mediate
uptake of different ligands.
Our gene expression data reveal that although TLR3,
TLR4, and TLR9 all induce expression of SRs, TLR9 ap-
pears to be the strongest inducer of SR-A, MARCO, and
LOX-1, as well as of phagocytosis. Because the induction
of these genes and phagocytosis of E. coli is dependent on
MyD88, it is not surprising that TLR9 has a high relative
affinity for this adaptor (Fig. 3 E). MARCO, LOX-1, and
SR-A were analyzed specifically in this manuscript because
they were all TLR induced, had steady-state mRNA, andDoyle et al. 89
protein levels that were dependent on the same signaling
cascade (MyD88–IRAK4–p38), and have all been shown
to be able to bind bacteria, including E. coli and S. aureus
(23). Despite these similarities, each of these SR genes dis-
played differential induction kinetics, thus further studies
will be required to understand the additional mechanisms
controlling their TLR-induced expression. Regardless, it is
evident that SRs are critical players in TLR-induced mac-
rophage phagocytosis of bacteria, and that they work in a
concerted manner. Besides TLR ligands, other stimuli may
also induce the surface expression of SRs. Previous and
current studies revealed that the SR levels are also up-regu-
lated in response to M-CSF, which explains why bone
marrow–derived murine macrophages (cultured in M-CSF)
have relatively high levels of SR expression compared with
RAW 264.7 cells (cultured without M-CSF [data not
shown]; references 28 and 29). There is even a possible re-
lationship between TLRs and M-CSF, as our gene chip
data indicated that all TLRs tested can induce expression of
M-CSF (data not shown). It is important to emphasize that,
besides the up-regulation of SRs, TLRs may likely up-
regulate the expression or activity of other molecules in-
volved in phagocytosis, which may not be able to be in-
duced by other stimuli such as M-CSF.
A number of reports have shown that both murine and
human TLRs play a vital role in host antibacterial re-
sponses. Systemic administration of CpG to bacterially in-
fected wild-type mice results in the suppression of bacte-
rial load (data not shown; and reference 39). Additionally,
mice deficient in either MyD88 or IRAK4 have shown
increased susceptibility to bacterial infection (27, 40). Re-
cent studies have also revealed that a mutation in the hu-
man IRAK4 gene is linked to the inability to clear bacte-
rial infections (41), and specific polymorphisms in human
TLR2 result in hyporesponsiveness to bacterial ligands
and impaired bacterial clearance by the host (42–44). It is
well known that TLRs and the MyD88 signaling pathway
play critical roles in pro-inflammatory cytokine produc-
tion, which is essential for antimicrobial responses. The
data presented in this manuscript provide an additional
explanation—that TLRs play an important role in pro-
moting clearance of bacteria through the up-regulation of
macrophage phagocytic activity through MyD88, IRAK4,
and p38.
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